HOME >> BIOLOGY >> NEWS
Rensselaer awarded NIH grant to support cheminformatics research

ed physics, and astronomy.

The center will be physically located in the Rensselaer Center for Biotechnology and Interdisciplinary Studies building with research collaborations occurring throughout campus and at other universities. After two years, the researchers will be eligible to apply for additional NIH funding to support a national resource center for cheminformatics.

Additional members of the Rensselaer faculty and staff involved in the RECCR project are: Kristin Bennett, professor of mathematical science; Wilfredo Colon, associate professor of chemistry and chemical biology; Steven Cramer, professor of chemical and biological engineering; Mark Embrechts, associate professor of decision sciences and engineering systems; Angel Garcia, senior constellation chaired professor in biocomputation and bioinformatics and professor of physics; Shekhar Garde, associate professor of chemical and biological engineering; James Moore, professor of chemistry and chemical biology; Nagamani Sukumar, senior research associate in chemistry and chemical biology; Mark Wentland, professor of chemistry and chemical biology; Mohammed Zaki, assistant professor of computer science; and Michael Zuker, professor of mathematical sciences.

"As Rensselaer continues its expansion into biotechnology and life sciences research, we applaud this interdisciplinary collaboration between researchers as an excellent illustration of how Rensselaer will contribute to accelerating discovery," said Omkaram "Om" Nalamasu, vice president for research.


'"/>

Contact: Tiffany Lohwater
lohwat@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
13-Oct-2005


Page: 1 2

Related biology news :

1. Rensselaer licenses microscope technology to Thorlabs
2. Rensselaer researchers develop approach that predicts protein separation behavior
3. Jan Lwe awarded 2007 EMBO Gold Medal
4. $9M grant awarded to University of Cincinnati for bipolar disorder research
5. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
6. CSHL awarded Pre-College Science Education Grant by HHMI
7. UD awarded $11M for osteoarthritis research and unique mentoring program for women scientists
8. UC Irvine awarded $3.9 million to upgrade stem cell research facilities, training
9. Computer science professor awarded $400,000 from National Science Foundation
10. Ocean observing contracts awarded to UC San Diego and University of Washington
11. Jaap Sinninghe Damst awarded the Vernadsky Medal for innovative use of biomarkers

Post Your Comments:
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... CER / 20% of sales) led the regional performance in the second quarter ... as solid contributions from Korea, India and ... / Africa (Q2 2015: +3% CER / ... Turkey and the United Kingdom . The Americas ... sales, on demand across all customer classes. The top seven emerging markets (Q2 ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... July 29, 2015  Indivior PLC (LON: INDV) today ... nasal spray was accepted and received Priority Review by ... treatment of opioid overdose. This naloxone nasal spray comes ... for optimal absorption into the nasal mucosa. 1 ... so individuals may be better equipped to help an ...
Breaking Biology Technology:GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
Cached News: